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Prothymosin ~z (ProTg) is a 12.5 kDa acidic polypeptide that is considered to have a nuclear function related to cell proliferation. Inspection of 
its amino acid sequence r vealed the presence of sequences that may serve as targets for phosphorylation by casein kinase-2 (CK-2). ProT~ isolated 
from calf thymocytes was phosphorylated in vitro by CK-2. The phosphc..~'iation sites are Ser and Thr residues located among the first 14 amino 
acid residues in the ProTa sequence. Another site that is theoretically suitable/'or phosphorylation byCK-2, at the C-terminus of the polypeptide, 
is not, in fact, phosphorylated. Thymosin cz~ (T~t), a peptide whose sequen~ corresponds tothe first 28 amil~o acids of ProT~, is also phosphorylated 
by CK-2 at the same phosphorylation sites as ProT~e. In cultured splenic lymphocytes ProTg was phosphorylated at Thr residues located at positions 
7, 12 and/or 13. Based on these observations we conclude that CK-2, or another celh,lar kinase with similar sequence specifity, is responsible for 
phosphorylation f ProTg in vivo. 
Prothymosin 0~; Thymosin r,;,; Casein kinase.2 
1. INTRODUCTION 
Prothymosin a is a 12.5 kDa acidic polypeptide that 
inelttdes at its N-terminus the sequences of thymosin gt 
and several related peptides [I]. The primary structures 
of ProT~z from diverse animal tissues are extremely sim- 
ilar [2], suggesting a high degree of conservation in the 
course of evolution. 
Although g-thymosins were originally considered to 
be involved in the immune response [3], the structure of 
the Pro'lcx gene [4] and the ubiquitous distribution of 
their putative precursor, ProT0t, in animal tissues [5,6] 
suggest hat ProT~ and/or its derived pel~tldes may have 
a more general cellular function that is still unknown. 
Recent studies point to a role for ProTg in cell prolifer- 
ation [6--8], and the presence of the karyophilic signal, 
TKKQKT, at its C-terminus (Fig. 1) is in keeping with 
evidence of its interacting with the nucleus [9,10]. 
Reports concerning the involvement ofcasein kinase- 
2, a Ser/Thr kinase using both ~'I'P and ATP as phos- 
phate donors [11], in the phosphorylation of high-mo- 
bility group proteins [12] and in protein transport be- 
tween the nucleus and cytoplasm [13], led us to realize 
that ProT0t from calf thymus and other sources [2] has 
three sites that are suitable for phosphorylation by CK- 
2, two at the N-terminus and one at the C-terminus (see 
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the calf thymocyte ProT0~ sequence shown in Fig. I). 
The proven involvement of CK-2 in cell proliferation 
[14] also relates this enzyme to ProTcz. 
In view of the above, we have sought phosphoamino 
acids in the ProT~ sequence and investigated the ability 
of CK-2 to phosphorylate ProT~ in vitro. In this paper 
we show that ProTcz from calf thymocytes i  phospho- 
rylated in vitro by rat liver CK-2 at Ser and Thr residues 
located among its first 14 amino residues. In cultured 
splenic lymphocytes, ProT~ was phosphorylated only at 
Thr residues located in the same N-terminal fragment 
in which ProT0~ is phosphorylated by CK-2. 
2. MATERIALS AND METHODS 
2.1. Materials 
The triethylammonium salts of adenosine 5'-[7)"P]triphosphate 
([7-~:P]ATP, 3,000 Ci/mmol) and of guanosine 5'-[7)2P]triphosphate 
([7-~-"P]GTP, 6,000 Ci/mmol), and [~"Plorthophosphate (1 Ci/mmol) 
were purchased from Du Pont-New England Nuclear. Poly.L-lysine 
hydrobromide, dephosphorylated ,8-casein from bovine milk, alkaline 
phosphatase from bovine intestinal mueesa (type VII), protamlne 
(grade IV) from salmon, heparin, ¢oncanavalin A and trypsin treated 
with L-l-tosylamido-2-phenylethyl c lorometlwl ketone, were pur- 
chased from Siffma. Cellulose thin-layer plates, 0.1 mm thick, were 
from E. Merck. lnterleukin-2 was obtained from Boehringer- 
Mannheim. ProTg was purified from calf thymocytes as described 
[16]. Rat liver cyto~ol CK-2 was a gift from Dr, E. Itarte (University 
of Barcelona, Barcelona, Spain). Synthetic T~ was a ~ift from Dr. 
I~.P. Heimer (Holt'mann-La Roche, Nutley, USA). All other reagents 
and materials were of analytical Brade. 
2.2. Phosphorylation f calf thyrnoeyte ProT~ and synthetic Tat 
The re.action mixture (25,~!) contained 50 mM Tris-HCI (pH 7.a), 
1.6 mM EOTA, 26 mM MgCI2, 0,1 mM [7'-a2P]ATP or [7-32P]GTP, 
1.6 mM EDTA, 83 mM fl-gly~rolphoaphate, 3.3 mM dithiothreitol 
and 150 mM KCI, in the presence or absence of ProT~ (5 btB), T~t (5 
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/ag) and/or at liver CK-2 (0.1 U), After 30 rain incubation at 370C, 
the reaction was stopped with 5/.tl of 100 mM ATP or GTP. The 
components of the reaction mixture we~ separated by SDS-PAGE 
following the Laemmli procedure [17], and the gels were stained, dried 
and autoradiographed. 
2.3. Analysis of phosphopeptldes 
[~:P]ProT0~ and [~-'P]T~ were purified l'rom the respective reaction 
mixtures by reverie-phase HPLC using a Vydac TP200-CI8 column 
(5/am, 4.6 × 250 ram) as described by France et al. [16]. Aliquots 
(180,000 epm) of the purified [uP]ProT~ or [~:P]T~t~ were digested with 
trypsin for 8 h at 37°C in the presence of 50/.tg of unlabeled polypep- 
tides. Separation of tryptic peptides was carried out by reverse-phase 
HPLC in an Ultrasphere ODS column (5/am, 4,6 ~ 250 ram). 
2,4. Phosphoamino acid analysis 
~-'P-Labeled tryptic peptides derived from [~'P]ProTa or [~:PlTat 
purified by HPLC were suspended in 500/21 of 6 N HCI, hydrolysed 
at 110°C for 2 h, diluted with water, lyophilized and dissolved in 20 
#1 of 50:5:945 acetic aeid/pyridinedwater (pH 3.5) (elcctrophoresis 
buffer) containing 0.5 pg/gtl each of phosphonerine and phozphothre- 
onine. This solution was subjected to one-dimensional thin-layer elee- 
trophoresis on cellulose plates for t h at 40C and 1,000 V [18]. After 
electrophoresls the cellulose plates were dried, stained with ninhydrin 
and autoradiographed on X-ray film to detect '~:P-labeled amino 
acids. 
2.5. Phosphorylation f ProT~r in rive 
Splenic lymphocytcs (14 × 107 ¢¢11s) obtained from 45-day-old fe- 
male BAL, B/¢ mi¢¢ were cultured for 20 h at 37°C in a humified 5% 
CO., atmosphere in 20 ml oforthophosphate-free RPMI-1640 medium 
containing 10% of dialysed foetal calf serum, 6 pg/ml of concanavalin 
A, 10 U/ml of interleukin-2 and 50 pCUml of [~'P]orthophosphate. 
Isolation of [~:PlProTa from splenic lymphocyte extracts was carried 
out using DEAE--cellulo~¢ chromatography andreverse-phase HPLC 
as described [16]. Analysis of phosphopeptides andphosphoamino 
acids of ProTct phosphorylated in rive was carried out as indicated 
above. 
3. RESULTS 
3.1. Phosphorylation fcalf thymocyte ProTa by CK-2 
and identification of the phospho~ytation sites 
In view of the presence of possible phosphorylation 
sites in the ProTa sequence (Fig. 1)~ we first investigated 
whether ProT~ purified from calf thymocytes without 
mitogenic stimulation contained phosphoryl groups 
bound to any of its Ser or Thr residues. Experiments to 
detect orthophosphate- bound Ser or Thr residues in 
ProT= treated with base [19] or after acid hydrolysis had 
negative results (data not shown). The possibility that 
ProT~x might be a substrate for CK-2 was then investi- 
gated by incubation of calf thymocyte ProT~x with CK-2 
purified from rat liver cytosol, which has been found 
not to contain other protein kinases 1"15]. The results 
(Fig. 2) indicate that CK-2 is able to phosphorylat¢ 
ProTct at a rate that is hardly affected by whether ATP 
or GTP is the co-substrate (Fig. 2, lanes 1 and 2). Like 
other authors [11], we found that the CK-2 ,~-subunit 
underwent autophosphory!ation (Fig. 2, lane 3), but 
ProT~x was not spontaneously phosphorylated (Fig. 2, 
lane 4). Treatment of the phosphorylated products with 
alkaline phosphatase r moved all [~2F']phosphate bound 
10 
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Fig. I. Amino acid sequence of calf thymus ProTet [2]. Sit~s theoreti- 
cally liable to phosphorylation by CK-2 are underlined. The box 
contains the nuclear targeting signal. 
to ProTcx and to the fl-subunit of CK-2 (Fig. 2, lane 5). 
~2P-Labeled ProT0t purified by reverse-phase HPLC 
had the same retention time (data not shown) and elee- 
trophoretic mobility (Fig. 2) as unphosphorylated 
ProT~x. 
In order to determine the phosphorylation sites of 
ProT~0 labeled and unlabeled polypeptide samples were 
digested with trypsin and the resulting peptides were 
separated by reverse-phase HPLC. The elution pattern 
(Fig. 3) showed phosphorylation f the N-terminal pep. 
tide (residues 1-14) of [32P]ProT~z, but no phospho- 
~lated peptides were obtained from the C.terminal re- 
gion where the other theoretical phosphorylation site 
for CK-2 is located (peptides 105-109 and 103-109 in 
Fig. 3). Thin-layer eleetrophoretic analysis of the acid 
hydrolysate of tlae N-terminal peptide purified by 
HPLC showed that Ser and Thr residues were phos- 
phorylated by CK-2 (inset A in Fig. 3). 
A similar phosphorylation pattern was observed 
among the tryptic peptides when synthetic T~ (the first 
28 amino acids of ProTcz) was used as the substrate for 
CK-2 (Fig. 4). Analysis by thin-layer eleetrophoresis of 
the acid hydrolysate of the N-terminal peptide (residues 
1-14) derived from tryptie digestion of Tcz~ indicated 
ProT,~ B "~"~"~"~"~"~'~  
1 2 3 4 5 
Fig. 2. Autoradiograph of products phospho~lated by CK-2 and 
separated by SDS-PAGE. Components in thu phosphorylation r~e- 
tion containing [7-~:P]ATP (lanes i, 3, 4, 5) or ~-~2P]GTP (lane 2) as 
phosphate donors, lacking ProTct (lane 3) or CK-2 (lane 4), and that 
indicated in Lane 1 after treatment as deserib,.-'d [24] with alkaline 
phosphatase (lane 5), were subjected to SDS-PAGE mid autoradio~ra- 
phed as indicated in Materials and Methods. CK-2 and ProTa mark 
the mobility of the [a:Plfl-subunit of CK-2 and of calf thymoeyte 
ProTa, respectively. 
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Fig. 3, HPLC of the peptides derived from the tryptie digestion of ~-P-labeled ProT~z. Peptides from the tryptie digestion of [~'~P]ProT~. (180,000 
cpm) and unlabeled ProT~z (50/zg) were separated by reverse-phase HPLC as indicated in Materials and Methods. The dlscontlnuous llne indicates 
the programmed gradient of acetonitrile in 0,1% trifluoroacetic a id. Fractions of 0,7 ml were collected every minute and their radioactivity 
determined. Arrows indicate the sequence of tryptic peptldes derived from calf thymus ProT~z the structure of which was confirmed by amino acid 
composition analysis, as described [16], The inset shows the phosphoamino acid analysis of the N-terminal tryptlc peptide (residues 1-14) derived 
from [~-~P]ProT~ phosphorylated by CK-2 (panel A) and from [-~zP]ProTg isolated from splenic lymphocytes labeled metabolically with [~"P]ortho- 
phosphate (panel B), Acid hydrolysates of the N-termlnal peptide purified by HPLC (20,000 epm) were separated by one-dimensional thin-layer 
clectrophoresis and autoradiographed as indicated in Materials and Methods, The positions of phosphoserine ($) and phosphothreonine (T) are 
marked. 
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Fig, 4, HPLC of the poptides derived from tryptic digestion of s:P-labelod T0q. Peptides from the t~ptic digestion of [~2P|T~ (180,000 cpm) and 
50/.tg of unlabeled T~z~ wore separated and analyzed as indicated in the legend of Fig, 3. Arrows indicate the sequence of tryptic peptides derived 
from synthetic Tat, The inset shows that the phosphoamino acid analysis ot' the N-terminal peptide (residues 1-14) of [~aP]TaA carried oat as 
indicated in Fig, 3. The positions of phosphoserin¢ (S) and phosphothreonin¢ (T) are marked. 
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Pr oTw..-  
Fig. 5. Isolation of phosphorylated ProT~t from cultured splenic lym- 
phocytes, [32P]ProTct was isolated as described inMaterials and Meth- 
ods and analyzed by SDS.PAGE followed by autoradiography. 
that, as in ProTcx0 Ser and Thr residues wore phosphor- 
ylated (inset in Fig. 4). 
3.2. Effect of activators and inhibitors on the phosphoryl- 
ation of Pro T~ 
Since polyamines have been shown to stimulate CK- 
2, we investigated the effects of protamine and polyly- 
sine on the phosphorylation f ProT~ by CK-2. Both 
polycations increased ~P~ incorporation 20-30-fold 
(Table I), in keeping with their effects on other CK-2 
substrates. Heparin, which has been reported as an effi- 
cient inhibitor of the phosphorylation f casein by CK- 
2, was not so efficient in inhibiting the labeling of ProTcx 
with 3-'P i (Table I), since .~ignifieant inhibition was only 
achieved by heparin concentrations about 3-times those 
required to inhibit phosphorylation f casein [11]. Note 
that heparin concentrations of 3-20/2g/ml have been 
used to inhibit he phosphorylation by CK-2 of proteins 
structurall~ related to ProT~, such as nucleolin [20], 
nueleoplasmin [21] and P1 [12]. 
3.3. Phosphorylation oJ'ProTo~ in rive 
In order to ascertain whether ProT~ is 
phosphorylated in rive, we cultured stimulated splenic 
lymphocytos in the presence of [3-~P]orthophosphate, 
and [3~-P]ProT~ was isolated using DEAE--eellulose 
chromatography and HPLC (Fig. 5). To determine the 
phosphorylation sites, labeled and unlabeled polypep- 
tide samples were digested with trypsin and the resulting 
peptides were separated by reverse-phase HPLC. The 
Table I 
Effect of activators and inhibltors on the ProTg phosphorylating 
activity of casein kinas¢-2 
Addition Concentration Casein-kinase activity 
None 
Hcparin 
Prommlne 
Polylysine 
1 
0.2/.tg/ml 0.99 
0.6/.tg/ml 0.47 
0.04 #lY//I 24.6 
0.08 ~//~1 30.7 
4/tM 20.1 
ProT0: was phosphorylated by CK-2 rains [7-~"P]ATP as the co- 
substrate, and the components of the diverse reaction mixtures were 
separated and analyzed as indicated in the legend of Fig. 2. CK-2 
activity was determined by optical dcnsitometry ofthe autoradiogram 
following gel eleetroplaoresis, an~d expressed relative to activity in the 
abscnc~ of cffectors. Results hown are the means of one experiment 
carried out in duplicate. A ~ccond experiment carried out in duplicate 
gave similar results. 
pattern of 3:P-labeled peptides was identical to the 
ProT~z phosphorylated by CK-2 (Fig. 3). However, 
thin-layer elcctrophoresis analysis of the acid hydroly- 
sate of the N-terminal peptide (residues 1-14) purified 
by HPLC showed that, in vireo only Thr residues are 
phosphorylated (inset B in Fig. 3). Identical results were 
obtained when we analyzed ProTg isolated from sub- 
confluent HeLa ceils incubated with [3:P]ortho- 
phosphate (data not shown). 
4. DISCUSSION 
The above results show that ProTcz from calf thy- 
mocytes is phosphorylat~! in vitro by CK-2 with an 
efficiency that is independent of whether ATP or GTP 
is the phosphate donor. ProTg was phosphorylated by
CK-2 exclusively at Set and Thr residues located at the 
N.terminal peptide that include the amino acid residues 
1-14. We also found that this peptide was the only one 
phosphorylated in cultured splenic lyrnphocytes, but ex- 
clusively at Thr residues. Therefore, we can conclude 
that, in vivo, ProTon is phosphorylated by CK-2 or an- 
other cellular kinase with similar sequence specificity. 
In our research on the in vivo phosphorylation f
ProTcx we found that the incorporation of [~:P]ortho- 
phosphate in the Thr residues of ProT~ was highly 
dependent on cell proliferation activity (unpublished re- 
suits). This fact is in keeping with our failure to detect 
phosphoamino acid residues in ProTct obtained from 
unstimulated calf thymocytes. 
The ubiquitous distribution of ProTcx in animal cells 
[5,6] and the evidence for its nuclear targeting [9,10] 
strongly suggest i s having some fundamental function 
in the nucleus. The finding that ProT0~ is phospho- 
rylated in rive supports this hypothesis, inasmuch that 
it is well documented that phosphorylation is involved 
in the activity [23] and import into the nucleus [13] of 
proteins that are structurally related to ProTg. How- 
ever, additional work is needed to elucidate the physio- 
logical significance of the phosphorylation f ProTct. 
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